Catalyst Event
Eli Lilly and Co (LLY) · Other
From Akros U.S. Large Cap 500 Protective Allocation Monthly Index (A500PAM)
4/10/2026, 12:00:00 AM
Expected FDA decision date for oral obesity drug orforglipron scheduled. High importance estimated as FDA decisions for major drugs typically cause >10% price swings.
Korean Translation
경구용 비만 치료제 올포글리프론(orforglipron)에 대한 FDA 승인 결정 예정일임. 주요 약물에 대한 FDA 결정은 통상 10% 이상의 주가 변동을 초래하므로 높은 중요도로 예상됨.
Related Recent Events
CrowdStrike Holdings Inc (CRWD) · Earnings Release
Next earnings release for Q1 2027 is scheduled for 2026-06-09, with analysts forecasting an EPS of $1.07 estimated.
6/9/2026, 12:00:00 AM
Biogen Inc (BIIB) · Other
U.S. FDA decision (PDUFA date) for LEQEMBI IQLIK (lecanemab) subcutaneous autoinjector for treatment initiation in Alzheimer's disease on 2026-05-24; high importance is estimated as FDA approval for a major drug formulation typically results in ≥10% price impact, scheduled.
5/24/2026, 12:00:00 AM
Walmart Inc (WMT) · Earnings Release
Walmart's earnings release for Q1 FY2027 is scheduled. A medium impact is estimated as earnings releases are key volatility drivers for retail stocks, expected.
5/21/2026, 12:00:00 AM
ONEOK Inc (OKE) · Other
ONEOK 2026 Annual Meeting of Shareholders on May 20, 2026, scheduled.
5/20/2026, 12:00:00 AM
Fair Isaac Corporation (FICO) · Other
FICO World 2026 is scheduled to take place from May 19-22, 2026.
5/19/2026, 12:00:00 AM
Alphabet Inc (GOOGL) · Other
Google I/O 2026 developer conference is scheduled for 2026-05-19. Developer conferences usually have a 1-5% price impact. Updates on AI, Gemini, and Android are expected.
5/19/2026, 12:00:00 AM